0001415889-21-004349.txt : 20210910
0001415889-21-004349.hdr.sgml : 20210910
20210910174253
ACCESSION NUMBER: 0001415889-21-004349
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210908
FILED AS OF DATE: 20210910
DATE AS OF CHANGE: 20210910
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LAMPROPOULOS FRED P
CENTRAL INDEX KEY: 0000901534
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-18592
FILM NUMBER: 211248000
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MERIT MEDICAL SYSTEMS INC
CENTRAL INDEX KEY: 0000856982
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 870447695
STATE OF INCORPORATION: UT
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1600 WEST MERIT PARK WAY
CITY: SOUTH JORDAN
STATE: UT
ZIP: 84095
BUSINESS PHONE: 8012531600
MAIL ADDRESS:
STREET 1: 1600 WEST MERIT PARKWAY
CITY: SOUTH JORDAN
STATE: UT
ZIP: 84095
4
1
form4-09102021_020944.xml
X0306
4
2021-09-08
0000856982
MERIT MEDICAL SYSTEMS INC
MMSI
0000901534
LAMPROPOULOS FRED P
1600 WEST MERIT PARKWAY
SOUTH JORDAN
UT
84095
true
true
false
false
PRESIDENT AND CEO
Common Stock, No Par Value
2021-09-08
4
M
0
5000
17.27
A
6269
I
By spouse
Common Stock, No Par Value
2021-09-08
4
F
0
2410
72.23
D
3859
I
By spouse
Common Stock, No Par Value
967916
D
Common Stock, No Par Value
95919
I
By 401(k) Plan
Common Stock, No Par Value
90
I
By spouse as custodian for child
Non-qualified stock options (right to buy)
17.27
2021-09-08
4
M
0
5000
0
D
2016-02-13
2022-02-13
Common Stock
5000
0
I
See footnote
Non-qualified stock options (right to buy)
16.05
2017-01-28
2023-01-28
Common Stock
50000
50000
D
Non-qualified stock options (right to buy)
16.05
2017-01-28
2023-01-28
Common Stock
6000
6000
I
See footnote
Non-qualified stock options (right to buy)
28.20
2018-04-14
2024-04-14
Common Stock
200000
200000
D
Non-qualified stock options (right to buy)
28.20
2018-04-14
2024-04-14
Common Stock
6000
6000
I
See footnote
Non-qualified stock options (right to buy)
44.80
2019-03-02
2025-03-02
Common Stock
38002
38002
D
Non-qualified stock options (right to buy)
44.80
2019-03-02
2025-03-02
Common Stock
4000
4000
I
See footnote
Non-qualified stock options (right to buy)
55.73
2020-03-01
2026-03-01
Common Stock
159151
159151
D
Non-qualified stock options (right to buy)
55.73
2020-03-01
2026-03-01
Common Stock
2000
2000
I
See footnote
Non-qualified stock options (right to buy)
37.71
2021-02-26
2027-02-26
Common Stock
100334
100334
D
Non-qualified stock options (right to buy)
56.25
2022-03-19
2028-03-19
Common Stock
58083
58083
D
Represents securities held by the spouse of the reporting person. The reporting person expressly disclaims beneficial ownership of the securities owned by his spouse.
Represents plan holdings as of 9/10/2021.
Became exercisable in equal annual installments of 20% commencing 2/13/2016.
Became exercisable in equal annual installments of 20% commencing 1/28/2017.
Original grant of 7,500 options was to become vested and exercisable in equal annual installments of 20% commencing 1/28/2017. Options not vested as of 6/22/2020 have been forfeited.
Becomes exercisable in equal annual installments of 20% commencing 4/14/2018.
Original grant of 10,000 options was to become vested and exercisable in equal annual installments of 20% commencing 4/14/2018. Options not vested as of 6/22/2020 have been forfeited.
Becomes exercisable in equal annual installments of 20% commencing 3/2/2019.
Original grant of 10,000 options was to become vested and exercisable in equal annual installments of 20% commencing 3/2/2019. Options not vested as of 6/22/2020 have been forfeited.
Becomes exercisable in equal annual installments of 20% commencing 3/1/2020.
Original grant of 10,000 options was to become vested and exercisable in equal annual installments of 20% commencing 3/1/2020. Options not vested as of 6/22/2020 have been forfeited.
Becomes exercisable in equal annual installments of 25% commencing 2/26/2021.
Becomes exercisable in equal annual installments of 25% commencing 3/19/2022.
/s/ Brian G. Lloyd, Attorney-in-Fact
2021-09-10